Microbiome 360° · 2026
Steven Theriault, PhD
PhD · CEO, Cytophage Technologies
Areas of expertise
- Bactériophages
- résistance aux antibiotiques
Biography
PhD in molecular genetics and virology, founder and CEO of Cytophage Technologies (Winnipeg). Former researcher at Canada's National Microbiology Laboratory (Ebola vaccine team), developing custom bacteriophages against antibiotic resistance.